Home / Brands / Gilead Sciences
Gilead Sciences Recalls
7 recalls on record · May 22, 2013 to October 9, 2024 · Drugs
Recalls by year
13
14
22
24
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
October 9, 2024DrugsFDA
Gilead Sciences, Inc. recalls Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Fos
Hazard: Presence of Particulate Matter: Presence of glass particle.
January 5, 2022DrugsFDA
Gilead Sciences, Inc. recalls Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Fos
Hazard: Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
November 5, 2014DrugsFDA
Gilead Sciences, Inc. recalls Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc., Foster
Hazard: Defective Container; leaking around the cap
October 15, 2014DrugsFDA
Gilead Sciences, Inc. recalls Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured
Hazard: Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
March 5, 2014DrugsFDA
Gilead Sciences, Inc. recalls Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx on
Hazard: Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.
July 31, 2013DrugsFDA
Gilead Sciences, Inc. recalls AmBisome (amphotericin B) liposome for Injection, 50 mg, For Intravenous Infusion Only, Single-Use Vial, Rx Only, Market
Hazard: Lack of Sterility Assurance; During a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in some media fill units. No contaminated batches have actually been identified in the finished product, but there is a possibility of contamination.
May 22, 2013DrugsFDA
Gilead Sciences, Inc. recalls Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc.
Hazard: Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).